Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.24.2.u1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 21,035,401 $ 4,224 $ 68,798,301 $ 104,718 $ (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Stock-based compensation expense 123,273   123,273    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 8,542,942 $ 972 8,541,970    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   971,532      
Other comprehensive income 61,104     61,104  
Net loss (4,477,778)       (4,477,778)
Ending balance at Mar. 31, 2023 25,284,942 $ 5,196 77,463,544 165,822 (52,349,620)
Ending balance, Shares at Mar. 31, 2023   5,195,826      
Beginning balance at Dec. 31, 2022 21,035,401 $ 4,224 68,798,301 104,718 (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Net loss (10,255,744)        
Ending balance at Jun. 30, 2023 19,464,380 $ 5,291 77,588,389 (1,714) (58,127,586)
Ending balance, Shares at Jun. 30, 2023   5,290,826      
Beginning balance at Dec. 31, 2022 21,035,401 $ 4,224 68,798,301 104,718 (47,871,842)
Beginning balance, Shares at Dec. 31, 2022   4,224,294      
Ending balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Ending balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Beginning balance at Mar. 31, 2023 $ 25,284,942 $ 5,196 77,463,544 165,822 (52,349,620)
Beginning balance, Shares at Mar. 31, 2023   5,195,826      
Stock-based compensation expense 124,845   124,845    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 95 $ 95      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   95,000      
Other comprehensive income (167,536)     (167,536)  
Net loss (5,777,966)       (5,777,966)
Ending balance at Jun. 30, 2023 19,464,380 $ 5,291 77,588,389 (1,714) (58,127,586)
Ending balance, Shares at Jun. 30, 2023   5,290,826      
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Beginning balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Stock-based compensation expense $ 53,434   53,434    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 397,607 $ 291 397,316    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   290,564      
Other comprehensive income (2,677)     (2,677)  
Net loss (4,649,635)       (4,649,635)
Ending balance at Mar. 31, 2024 6,776,651 $ 6,477 78,322,334 (1,800) (71,550,360)
Ending balance, Shares at Mar. 31, 2024   6,476,844      
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 77,871,584 877 (66,900,725)
Beginning balance, Shares at Dec. 31, 2023 6,186,280 6,186,280      
Net loss $ (9,609,243)        
Ending balance at Jun. 30, 2024 $ 5,096,649 $ 7,216 81,600,425 (1,024) (76,509,968)
Ending balance, Shares at Jun. 30, 2024 7,216,145 7,216,145      
Beginning balance at Mar. 31, 2024 $ 6,776,651 $ 6,477 78,322,334 (1,800) (71,550,360)
Beginning balance, Shares at Mar. 31, 2024   6,476,844      
Stock-based compensation expense 30,697   30,697    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 3,248,133 $ 739 3,247,394 0  
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   739,301      
Other comprehensive income 776     776  
Net loss (4,959,608)       (4,959,608)
Ending balance at Jun. 30, 2024 $ 5,096,649 $ 7,216 $ 81,600,425 $ (1,024) $ (76,509,968)
Ending balance, Shares at Jun. 30, 2024 7,216,145 7,216,145